IIM
VYGR icon

INTECH Investment Management’s Voyager Therapeutics VYGR Stock Holding History

INTECH Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.6K Buy
13,316
+1,048
+9% +$3.97K ﹤0.01% 2064
2026
Q1 		$47.4K Sell
12,268
-6,704
-35% -$26.4K ﹤0.01% 2009
2025
Q4 		$74.6K Sell
18,972
-2,273
-11% -$10.1K ﹤0.01% 2213
2025
Q3 		$99.2K Sell
21,245
-5,302
-20% -$19.2K ﹤0.01% 2268
2025
Q2 		$82.6K Sell
26,547
-6,890
-21% -$22.2K ﹤0.01% 2338
2025
Q1 		$113K Buy
33,437
+11,311
+51% +$52.8K ﹤0.01% 2283
2024
Q4 		$125K Buy
22,126
+9,412
+74% +$60.7K ﹤0.01% 2158
2024
Q3 		$74.4K Buy
+12,714
New +$92.4K ﹤0.01% 1936

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

INTECH Investment Management's VYGR Position: Q2 2026 in Review

INTECH Investment Management increased its Voyager Therapeutics (VYGR) stake by 8.5% in Q2 2026, buying an estimated $3.97K and bringing the position to 13,316 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

INTECH Investment Management first reported a position in VYGR in Q3 2024 and has held it in 8 quarters since. The position peaked at $125K in Q4 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • INTECH Investment Management held 13,316 shares of Voyager Therapeutics worth $46.6K as of Q2 2026.
  • INTECH Investment Management bought 1,048 Voyager Therapeutics shares in Q2 2026, an estimated $3.97K.
  • Voyager Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2064 holding.
  • INTECH Investment Management first reported a position in Voyager Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Voyager Therapeutics position peaked at $125K in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.